Disrupting Type 2 Diabetes: Mounjaro's UK Launch

In this ‪@GoggleDocs‬ video, Patrick and Amrit discuss the launch of Mounjaro, the latest blockbuster medication in the management of type 2 diabetes. Already launched in the in USA, with people having significant reductions in HbA1c and weight, the UK launch has been hotly anticipated. However, the current global shortage of GLP-1 agonists, remains a concern for many healthcare professionals and people living with diabetes.

For more discussion, join us on X: ‪@GoggleDocs‬

TIMESTAMPS:

00:00:00 - Introduction and Background
00:01:17 - What is Mounjaro?
00:03:34 - The significant positive effects of Mounjaro
00:04:22 - Adverse effects
00:05:08 - Evidence (SURPASS-1)
00:06:12 - Dose Titration
00:06:40 - NICE recommendation
00:07:58 - Practicalities & Implementation
00:10:50 - Supply Concerns
00:13:35 - Closing Thoughts

RESOURCES:

https://www.nice.org.uk/guidance/ta924
https://investor.lilly.com/news-relea...
https://www.thelancet.com/journals/la...

CREDITS:

Images: Flaticon.com - Flat Icons, Freepik, Icons Box
Music: Sound Mind by Matt Large, composed by Mattias Hedbom